Upgrading our NAV; Babylon goes the SPAC route
03/06/21 -"We updated our estimated DCF following the announcement of Babylon Health's definitive merger agreement with the SPAC Alkuri Global, through which the London-based digital healthcare company will ..."
Pages
61
Language
English
Published on
03/06/21
You may also be interested by these reports :
10/07/26
Our EPS for 2026 is benefitting from the announcement of an exceptional dividend by Banijay of €0.93 per share, thus increasing the expected ...
08/07/26
Our EPS for 2026 is benefitting from the positive change in fair value of financial assets of SEK 9bn compared to our last estimate, having a similar ...
08/07/26
Industrivarden has just released good Q2 26 results despite Iran war worries, as it is exposed to names relatively preserved from the Middle East ...
07/07/26
Our target price is benefitting from the increase in the fair value of financial assets, which have positively impacted most of our valuation ...